Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4744

1.

The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response.

Lavoie S, Conway KL, Lassen KG, Jijon HB, Pan H, Chun E, Michaud M, Lang JK, Gallini Comeau CA, Dreyfuss JM, Glickman JN, Vlamakis H, Ananthakrishnan A, Kostic A, Garrett WS, Xavier RJ.

Elife. 2019 Jan 22;8. pii: e39982. doi: 10.7554/eLife.39982.

2.

Mitochondrial neurogastrointestinal encephalopathy: a clinicopathological mimic of Crohn's disease.

Patel R, Coulter LL, Rimmer J, Parkes M, Chinnery PF, Swift O.

BMC Gastroenterol. 2019 Jan 15;19(1):11. doi: 10.1186/s12876-018-0925-5.

4.

Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage.

Panchal H, Wagner M, Chatterji M, Taouli B, McBride R, Patterson JR, Ungaro R, Dubinsky M, Cho J, Sachar DB.

Dig Dis Sci. 2019 Jan 3. doi: 10.1007/s10620-018-5434-4. [Epub ahead of print]

PMID:
30607690
5.

Lower expression of endogenous intestinal alkaline phosphatase may predict worse prognosis in patients with Crohn's disease.

Park SY, Kim JY, Lee SM, Chung JO, Seo JH, Kim S, Kim DH, Park CH, Ju JK, Joo YE, Lee JH, Kim HS, Choi SK, Rew JS.

BMC Gastroenterol. 2018 Dec 17;18(1):188. doi: 10.1186/s12876-018-0904-x.

6.

Osteoporosis complicating some inborn or acquired diseases.

Zofkova I, Nemcikova P.

Physiol Res. 2018 Nov 28;67(Supplementum 3):S441-S454. Review.

7.

Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study.

Ziade F, Rungoe C, Kallemose T, Paerregaard A, Wewer AV, Jakobsen C.

Dig Dis. 2019;37(2):140-146. doi: 10.1159/000494215. Epub 2018 Nov 13.

PMID:
30423580
8.

Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative Colitis.

Dobre M, Milanesi E, Mănuc TE, Arsene DE, Ţieranu CG, Maj C, Becheanu G, Mănuc M.

J Immunol Res. 2018 Oct 17;2018:9208274. doi: 10.1155/2018/9208274. eCollection 2018.

9.

Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.

Nanini HF, Bernardazzi C, Castro F, de Souza HSP.

World J Gastroenterol. 2018 Nov 7;24(41):4622-4634. doi: 10.3748/wjg.v24.i41.4622. Review.

10.

Lipid and Bile Acid Dysmetabolism in Crohn's Disease.

Uchiyama K, Kishi H, Komatsu W, Nagao M, Ohhira S, Kobashi G.

J Immunol Res. 2018 Oct 1;2018:7270486. doi: 10.1155/2018/7270486. eCollection 2018. Review.

11.

Association of polymorphic variants in serotonin re-uptake transporter gene with Crohn's disease: a retrospective case-control study.

Grubelic Ravić K, Paić F, Vucelić B, Brinar M, Čuković-Čavka S, Božina N, Krznarić Ž, Kalauz M, Bešić D, Nikuševa Martić T.

Croat Med J. 2018 Oct 31;59(5):232-243.

12.

Identification of novel susceptibility genes associated with seven autoimmune disorders using whole genome molecular interaction networks.

Kara S, Pirela-Morillo GA, Gilliam CT, Wilson GD.

J Autoimmun. 2019 Feb;97:48-58. doi: 10.1016/j.jaut.2018.10.002. Epub 2018 Nov 1.

PMID:
30391024
13.

Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease.

El Mouzan MI, Korolev KS, Al Mofarreh MA, Menon R, Winter HS, Al Sarkhy AA, Dowd SE, Al Barrag AM, Assiri AA.

World J Gastroenterol. 2018 Oct 21;24(39):4510-4516. doi: 10.3748/wjg.v24.i39.4510.

14.

Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea.

Tronstad RR, Polushina T, Brattbakk HR, Stansberg C, von Volkmann HL, Hanevik K, Ellinghaus E, Jørgensen SF, Ersland KM, Pham KD, Gilja OH, Hovdenak N, Hausken T, Vatn MH, Franke A, Knappskog PM, Le Hellard S, Karlsen TH, Fiskerstrand T.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1264-1273. doi: 10.1080/00365521.2018.1521867. Epub 2018 Oct 24.

PMID:
30353760
15.

Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data.

Tylee DS, Sun J, Hess JL, Tahir MA, Sharma E, Malik R, Worrall BB, Levine AJ, Martinson JJ, Nejentsev S, Speed D, Fischer A, Mick E, Walker BR, Crawford A, Grant SFA, Polychronakos C, Bradfield JP, Sleiman PMA, Hakonarson H, Ellinghaus E, Elder JT, Tsoi LC, Trembath RC, Barker JN, Franke A, Dehghan A; 23 and Me Research Team; Inflammation Working Group of the CHARGE Consortium; METASTROKE Consortium of the International Stroke Genetics Consortium; Netherlands Twin Registry; neuroCHARGE Working Group; Obsessive Compulsive and Tourette Syndrome Working Group of the Psychiatric Genomics Consortium, Faraone SV, Glatt SJ.

Am J Med Genet B Neuropsychiatr Genet. 2018 Oct;177(7):641-657. doi: 10.1002/ajmg.b.32652. Epub 2018 Oct 16.

PMID:
30325587
16.

Role of microRNA-223 in the regulation of poly(ADP-ribose) polymerase in pediatric patients with Crohn's disease.

Judit Béres N, Kiss Z, Müller KE, Cseh Á, Veres-Székely A, Lippai R, Benkő R, Bartha Á, Heininger S, Vannay Á, Sziksz E, Veres G, Horváth EM.

Scand J Gastroenterol. 2018 Sep;53(9):1066-1073. doi: 10.1080/00365521.2018.1498915. Epub 2018 Oct 9.

PMID:
30299179
17.

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease.

Gaetani E, Del Zompo F, Marcantoni M, Gatto I, Giarretta I, Porfidia A, Scaldaferri F, Laterza L, Lopetuso L, Gasbarrini A, Pola R.

Int J Mol Sci. 2018 Sep 26;19(10). pii: E2921. doi: 10.3390/ijms19102921.

18.

Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel.

Hiraishi K, Kurahara LH, Sumiyoshi M, Hu YP, Koga K, Onitsuka M, Kojima D, Yue L, Takedatsu H, Jian YW, Inoue R.

World J Gastroenterol. 2018 Sep 21;24(35):4036-4053. doi: 10.3748/wjg.v24.i35.4036.

19.

FKBP11 protects intestinal epithelial cells against inflammation‑induced apoptosis via the JNK‑caspase pathway in Crohn's disease.

Wang X, Cui X, Zhu C, Li M, Zhao J, Shen Z, Shan X, Wang L, Wu H, Shen Y, Ni Y, Zhang D, Zhou G.

Mol Med Rep. 2018 Nov;18(5):4428-4438. doi: 10.3892/mmr.2018.9485. Epub 2018 Sep 14.

20.

Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease.

Richard AC, Peters JE, Savinykh N, Lee JC, Hawley ET, Meylan F, Siegel RM, Lyons PA, Smith KGC.

PLoS Genet. 2018 Sep 10;14(9):e1007458. doi: 10.1371/journal.pgen.1007458. eCollection 2018 Sep.

Supplemental Content

Loading ...
Support Center